Delivery Order SPE2DB22D2206-SPE2DB24FHL78
- Not listed
- This federal contract award, valued at $14,295.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of GAMUNEX-C 20 GRAM/200 ML VIAL 200ML, a pharmaceutical product, with a completion date of July 18, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December...
- This federal contract award, valued at $36,068.40, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is a delivery order for the pharmaceutical product GAMUNEX-C, a 10 gram/100 ml vial. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,462.92 firm fixed-price delivery order is for the supply of GAMUNEX-C 40 GRAM/400 ML VIAL 400 ML medical products. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $14,295.00 awarded to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the delivery of GAMUNEX-C 20 GRAM/200 ML VIAL 200ML, a pharmaceutical product, with a period of performance through September 26, 2024. AmerisourceBergen is one of the largest pharmaceutical distributors in the United States and has been awarded numerous federal contracts to provide a wide range...
- This federal contract award, valued at $9,308.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for GAMUNEX-C 40 GRAM/400 ML VIAL 400ML, a pharmaceutical product, with an ultimate completion date of July 24, 2025. The contract is a firm fixed-price arrangement, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,125.92 firm-fixed-price delivery order is for the supply of 4566734911 - GAMUNEX-C 20 GRAM/200 ML VIAL 200ML. The contract has an ultimate completion date of January 8, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, worth $14,427.24, is a delivery order for the supply of GAMUNEX-C 40 gram/400 ML vials. The contract has a firm fixed price and an ultimate completion date of November 15, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of GAMUNEX-C 5 GRAM/50 ML VIAL 50ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,479.65 and an ultimate completion date of May 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, is for the delivery of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML to the Defense Logistics Agency (DLA). The firm fixed-price contract has a ceiling value of $28,854.48 and an ultimate completion date of July 22, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the...
- This federal contract award, valued at $14,427.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Firm Fixed Price Delivery Order for the provision of 4564376644 ! GAMUNEX-C 40 GRAM/400 ML VIAL 400ML, a pharmaceutical product. The contract has an ultimate completion date of May 14, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FHL78Delivery Order
This federal contract award, valued at $14,295.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564741602 - GAMUNEX-C 20 GRAM/200 ML VIAL 200ML, a pharmaceutical product, with a completion date of June 20, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract award does not have a set-aside designation, indicating it was awarded on a full and open competition basis. AmerisourceBergen's expertise in pharmaceutical distribution and its extensive supply chain network have contributed to its competitive position in securing federal contracts to supply critical medical products to various government agencies, including the Department of Defense and the Department of Justice.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.3k | 5/29/24 |